NCT03032406 2025-07-22CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast CancerAbramson Cancer Center at Penn MedicinePhase 2 Active not recruiting53 enrolled 12 charts